Myocardial fibrosis has been proposed to play an important pathogenetic role in left ventricular (LV) dysfunction in obesity. This study tested the hypothesis that calibrated integrated backscatter (cIB) as a marker of myocardial fibrosis is altered in obese adolescents and explored its associations with adiposity, LV myocardial deformation, and metabolic parameters.
Fifty-two obese adolescents and 38 non-obese controls were studied with conventional and speckle tracking echocardiography. The average cIB of ventricular septum and LV posterior wall was measured. In obese subjects, insulin resistance as estimated by homeostasis model assessment (HOMA-IR) and glucose tolerance were determined. Compared with controls, obese subjects had significantly greater cIB of ventricular septum (-16.8±7.8 dB vs -23.2±7.8 dB, p<0.001), LV posterior wall (-20.5±5.6 dBvs -25.0±5.1 dB, p<0.001) and their average (-18.7±5.7 dB vs -24.1±5.0 dB, p<0.001). For myocardial deformation, obese subjects had significantly reduced LV longitudinal systolic strain rate (SR) (p = 0.045) and early diastolic SR (p = 0.015), and LV circumferential systolic strain (p = 0.008), but greater LV longitudinal late diastolic SR (p<0.001), and radial early (p = 0.037) and late (p = 0.002) diastolic SR than controls. For the entire cohort, myocardial cIB correlated positively with body mass index (r = 0.45, p<0.001) and waist circumference (r = 0.45, p<0.001), but negatively with LV circumferential systolic strain (r = -0.23, p = 0.03) and systolic SR (r = -0.25, p = 0.016). Among obese subjects, cIB tended to correlate with HOMA-IR (r = 0.26, p = 0.07).
Citation: Xie L, Man E, Cheung P-t, Cheung Y-f (2015) Myocardial Integrated Backscatter in Obese Adolescents: Associations with Measures of Adiposity and Left Ventricular Deformation. PLoS ONE10(10): e0141149. https://doi.org/10.1371/journal.pone.0141149
Editor: Xiongwen Chen, Temple University, UNITED STATES
Received: April 28, 2015; Accepted: October 4, 2015; Published: October 22, 2015
Copyright: © 2015 Xie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: The restrictions from the Institutional Review Board of The University of Hong Kong/Hospital Authority West Cluster, Hong Kong prohibit the authors from making the minimal data set publicly available. Interested researchers may contact Dr Yiu-fai Cheung (email: firstname.lastname@example.org) to request the data.
Funding: The authors have no support or funding to report.
Competing interests: The authors have declared that no competed interests exist.
Childhood obesity has become a global epidemic involving not only developed but also developing countries. Among the various co-morbidities, left ventricular (LV) dysfunction remains to be the most significant cause of morbidity and mortality.[2, 3] Importantly, myocardial fibrosis has been proposed to play an important pathogenetic role in ventricular dysfunction in obesity.[4–6] Experimental studies have provided evidence of dysregulation of the myocardial fibrotic process in obesity and metabolic dysfunction, which probably involves the activation of renin-angiotensin-aldosterone system and induction of oxidative stress.[7–9]
Whether increased myocardial fibrosis occurs in obese children is, however, unknown. Limited data suggest that this may be the case in obese adults. Myocardial biopsy to quantify the amount of fibrous tissue is invasive and impractical. On the other hand, noninvasive assessment of myocardial fibrosis by echocardiographically-derived calibrated integrated backscatter (cIB) has been used in both adults [10, 11] and children  to provide an estimate of myocardial fibrosis.
Alteration of myocardial composition and architecture may affect myocardial mechanics. Conventional echocardiographic assessment of LV function in obese subjects has nonetheless relied on measuring LV ejection fraction, which often yielded normal results. On the other hand, direct interrogation of myocardial deformation compared with simple quantification of ventricular volume changes has been shown to be more sensitive in the early detection of subtle ventricular dysfunction. In particular, two-dimensional strain imaging by speckle tracking echocardiography (STE) is increasingly used to evaluate ventricular performance in children with congenital [15,16] and acquired  heart diseases.
In the present study, we aimed to test the hypothesis that cIB is altered in obese adolescents compared with non-obese subjects. Furthermore, we explored its associations with measures of adiposity, indices of LV myocardial deformation, and, in obese adolescents, metabolic parameters including homeostasis model assessment of insulin resistance (HOMA-IR) and glucose tolerance.
A total of 52 obese adolescents and 38 non-obese healthy adolescents aged 14 to 20 years were studied. Obese subjects were recruited consecutively from the paediatric clinic, while non-obese controls are friends of hospital staff and volunteers recruited from the community. The obese phenotype is defined by body mass index (BMI) at or above 95 percentile for children and adolescents of the same age and sex. Exclusion criteria included documented congenital or acquired heart diseases and current use of cardiovascular medications. Weight and height were measured and BMI was calculated accordingly. Waist circumference was measured at the midpoint between the lowest part of costal margin and highest point of the iliac crest in the mid-axillary line. Blood pressure of the right arm was measured three times with an automated oscillometric device (Dinamap, Critikon Inc, Tampa, USA) after the subjects had taken a rest for at least 15 minutes, and the average was used for analyses.
This study was approved by the Institutional Review Board of The University of Hong Kong/ Hospital Authority West Cluster, Hong Kong and informed written consent was obtained from all subjects and parents on behalf of minors.
Conventional and tissue Doppler echocardiographic assessment
Echocardiographic examination was performed using Vivid 7 ultrasound machine (GE Medical System, Horten, Norway). Acquired data were stored digitally and analyzed offline using the EchoPAC software (GE Medical System, Horten, Norway). Average values of echocardiographic indices based on readings from three cardiac cycles were used for statistical analyses.
M-mode echocardiography was performed from the standard parasternal short-axis view for measurement of the following indices: LV end-systolic and end-diastolic dimensions, shortening fraction, septal and LV posterior wall thickness, and LV mass.
From the four-chamber view, pulsed-wave Doppler examination was performed to determine transmitral peak early (E) and late (A) diastolic velocities, E wave deceleration time, and E/A ratio. Colour tissue Doppler imaging of the LV lateral wall was performed with frame rates >100 Hz. With the sample volume positioned at the LV lateral wall-mitral annular junction, the mitral annular peak myocardial velocities at systole (s), early diastole (e), and late diastole (a) were measured and the mitral E/e ratio was also calculated. The relatively load-independent index of ventricular systolic function, myocardial acceleration during isovolumic contraction (IVA), was also measured as reported.
Speckle tracking echocardiography
Left ventricular myocardial deformation was assessed also using EchoPAC software (General Medical System, Horten, Norway). From the four-chamber view, LV global longitudinal systolic strain and systolic and diastolic strain rate (SR) were measured. Based on the mid-ventricular parasternal short-axis plane, LV global systolic circumferential and radial strain and systolic and diastolic SR were measured. Our group has previously reported on high intra- and inter-observer reproducibility of STE in measuring LV myocardial deformation.
Calibrated integrated backscatter
Integrated backscatter of the ventricular septum and posterior LV wall at the mid-ventricular level was determined at end-diastole from the parasternal short-axis view. The sample volume was tracked manually to maintain the same region throughout the heart cycle. Myocardial cIB was calculated as the difference between integrated backscatter at the two sites and that of the pericardium. The average cIB at the two sites was derived for correlation analysis. The intra- and interobserver variability for CIB measurement was 4.9% and 6.5%, respectively.
Assessment of glucose tolerance and insulin resistance
Oral glucose tolerance test was performed in the obese group in the morning after overnight fasting after echocardiographic assessment. Normal and impaired glucose tolerance and diabetes mellitus were defined according to standard guidelines. The HOMA-IR was calculated as fasting plasma glucose (in mmol/l) x fasting serum insulin (in mU/l) / 22.5.
Data are presented as mean±SD unless otherwise stated. Absolute values of strain and strain rates are presented to facilitate interpretation and analyses. Demographic and echocardiographic parameters between obese and non-obese cohorts were compared using unpaired Student's t test. The LV mass was indexed by both body surface area and height1.7, the latter being reported to be more sensitive for identification of obesity-related LV hypertrophy. Pearson correlation analysis was used to determine associations between myocardial cIB and measures of body adiposity, indices myocardial deformation, and metabolic parameters. Adjustments of correlations for systemic blood pressure were made by linear regression analysis. A p value <0.05 is considered statistically significant. All statistical analyses were performed using SPSS version 16.0 (SPSS Inc, Chicago, Illinois, USA).
The 52 (25 males) obese adolescents were studied at 17.8±1.7 years, while the 38 (17 males) non-obese controls were studied at 18.1±2.1 years (p = 0.39). Table 1 summarizes their clinical characteristics. The BMI (p<0.001) and waist circumference (p<0.001) were expectedly greater in the obese cohort. Systolic (p<0.001) and diastolic (p<0.001) blood pressures were significantly higher in obese subjects compared with non-obese ones. Of the 52 obese subjects, 38 had normal glucose tolerance, 9 had type 2 diabetes mellitus, and 5 had impaired glucose tolerance.
Conventional and Doppler echocardiographic parameters
Table 2 summarizes the echocardiographic parameters of the two groups. Compared with controls, obese subjects had significantly greater septal (p<0.001) and LV posterior wall (p<0.001) thickness at diastole and LV mass (p<0.001) even with adjustment of the latter for body surface area (p<0.001). The LV end-diastolic (p<0.001) and systolic (p = 0.006) dimensions were significantly greater in patients than controls, while their shortening fraction (p = 0.26) were similar.
For Doppler parameters, obese subjects had significantly greater transmitral A velocity (p = 0.008), mitral annular a velocity (p = 0.026), and E/e ratio (p = 0.034), but lower mitral annular s velocity (p = 0.016) and e/a ratio (p = 0.013).
Myocardial cIB of the ventricular septum (-16.8±7.8 dB vs -23.2±7.8 dB, p<0.001), LV posterior wall (-20.5±5.6 dB vs -25.0±5.1 dB, p<0.001) and average cIB of the two sites (-18.7±5.7 dB vs -24.1±5.0 dB, p<0.001) were significantly greater in obese compared with non-obese subjects (Fig 1). Even with exclusion of the 9 obese subjects with diabetes mellitus, the remaining 43 obese subjects had similarly greater average cIB compared with controls (-18.87±5.43 dB vs -24.08±4.97 dB, p<0.001).
Fig 2 shows the strain and strain rate of the two groups in three dimensions. Compared with controls, obesity subjects had significantly reduced LV longitudinal systolic SR (0.77±0.14 /s vs 0.83±0.14 /s, p = 0.045) and early diastolic SR (1.23±0.29 /s vs 1.38±0.30 /s, p = 0.015), and LV circumferential systolic strain (14.1±3.4% vs 16.0±3.1%, p = 0.008). On the other hand, obese subjects had significantly greater LV longitudinal late diastolic SR (0.52±0.11 /s vs 0.44±0.09 /s, p<0.001), and radial early (2.18±0.56 /s vs 1.94±0.48 /s, p = 0.037) and late (1.20±0.46 /s vs 0.88±0.53 /s. p = 0.002) diastolic SR (Fig 2).
When stratified by the presence (n = 14) or absence (n = 38) of glucose intolerance in obese subjects, no differences in myocardial deformation parameters were found (Table 3).
On the other hand, there were greater correlations between waist circumference and myocardial deformation parameters than those between BMI and the latter (Table 4). Even after adjustment for systolic and diastolic blood pressures, the waist circumference was found to correlate negatively with LV longitudinal systolic strain (p = 0.027), systolic SR (p = 0.02), early diastolic SR (p = 0.004) and circumference systolic strain (p = 0.007) and systolic SR (p = 0.05) and positively with radial late diastolic SR (p = 0.002).
Correlates of cIB
For the entire cohort, the average myocardial cIB correlated positively with BMI (r = 0.45, p<0.001), waist circumference (r = 0.45, p<0.001) and negatively with LV circumferential systolic strain (r = -0.23, p = 0.030) and systolic SR (r = -0.25, p = 0.016) (Fig 3), but not with other deformation parameters. The correlations between cIB and BMI, waist circumference, and circumferential systolic SR remained significant even after exclusion of obese subjects with diabetes mellitus (all p<0.05). Among obese subjects, cIB also tended to correlate positively with HOMA-IR (r = 0.26, p = 0.07).
The present study demonstrates increased myocardial cIB suggestive of myocardial fibrosis and impaired LV myocardial deformation along the longitudinal and circumferential dimensions in obese adolescents. Additionally, myocardial cIB was found to associate positively with waist circumference and BMI and negatively with LV circumferential deformation.
In rodent models of obesity, cardiac remodeling with ventricular hypertrophy and increased interstitial fibrosis have been described.[5, 23, 24] Direct histological evidence of myocardial fibrosis in human obese subjects is, however, limited. Nevertheless, previous clinical studies have provided evidence of altered myocardial extracellular matrix turnover with possible predisposition to increased interstitial fibrosis in adults. In premenopausal obese woman, altered circulating profile of matrix metalloproteinases and their tissue inhibitors has been described, although the absence of histological specimens forbids prediction of the net result on extracellular matrix turnover in this study. On the other hand, procollagen type III aminopeptide, a circulating marker of collagen synthesis, was found to be increased in obese adults and to correlate positively with the severity of insulin resistance. Recently, a randomized controlled trial of aldosterone blockade in middle-aged obese adults showed reduction of circulating procollagen levels coupled with improved myocardial cIB and LV function, implicating a possible pathogenetic role of myocardial fibrosis. Little, however, is known on the myocardial fibrotic process in obese children. To our knowledge, this is the first study to interrogate myocardial fibrosis and its association with measures of adiposity and myocardial deformation in obese children. The finding of greater myocardial cIB in obese adolescents suggests that increased fibrosis of the myocardium starts since childhood.
Changes in extracellular matrix composition may have functional implications on LV mechanics. Previous studies on LV systolic function in obese subjects by quantification of ejection fraction usually yielded normal results. On the other hand, assessment of myocardial mechanics by strain imaging may provide better assessment of ventricular contractility. The findings of impaired LV systolic deformation along the longitudinal and circumferential dimensions in the obese cohort agree with those reported previously.[27, 28] Our additional findings of negative correlations between myocardial cIB and circumferential systolic strain and SR probably represent functional translation of altered myocardial extracellular matrix. These findings corroborate the associations between cIB and basal septal strain and SR reported in adults with metabolic syndrome  and provide evidence of interplay between myocardial fibrosis and systolic dysfunction in obesity. Interstitial fibrosis has indeed been linked to impaired LV contractile performance in the setting of aortic regurgitation, while perivascular fibrosis may reduce coronary flow reserve to cause contractile dysfunction.
Fibrous tissue deposition may increase myocardial stiffness and lead to ventricular diastolic dysfunction. This is the first study to explore diastolic myocardial deformation using STE in obese children. While we did not find statistically significant correlations between cIB and indices of diastolic function, reduced LV longitudinal early diastolic SR and higher E/e ratio in our obese cohort may reflect respectively ventricular relaxation abnormality and greater LV filling pressure. The latter concurs with findings of previous studies in obese children.[27, 31] Furthermore, the greater late diastolic transmitral and mitral annular velocities and late diastolic longitudinal and radial SR implicate greater reliance on atrial filling in obese adolescents. Reduced atrial deformation reported in obese children  may, however, limit the degree of atrial compensation. The discrepant association between calibrated integrated backscatter with ventricular systolic and diastolic deformation may perhaps be related to the degree of myocardial fibrosis. Mild fibrosis may not significantly alter ventricular compliance and diastolic function, although subtle subclinical alteration of systolic deformation may already be detectable using the sensitive speckle tracking echocardiography.
Associations of measures of body adiposity, in particular waist circumference, with myocardial cIB and deformation indices even after adjustment of systemic blood pressure are of clinical importance. Body mass index and waist circumference, with the latter having a greater sensitivity, can predict clustering of traditional cardiovascular risk factors in children.[32, 33] Our findings suggest potential inclusion of subclinical LV dysfunction to this list of risk factors. While the mechanistic link between adiposity and myocardial fibrosis in our subjects is not entirely clear, experimental studies have shown that the adipokine leptin could induce cardiac fibrosis through activation of the mTOF pathway, increase in oxidative stress, and finally production of galectin-3 to stimulate collagen deposition. The negative associations between adiposity and longitudinal and circumferential deformation found in this study corroborate the findings of Peterson et al, who reported on negative associations between BMI and systolic and early diastolic myocardial velocities in obese women. Whether the observed ‘dose-response’ relationships between adiposity and subtle subclinical LV systolic and diastolic dysfunction is directly related to cardiac remodeling and alteration of myocardial extracellular matrix or indirectly through the effects of systemic hypertension require further clarification.
Within our relatively small obese paediatric cohort, the HOMA-IR tended to correlate with myocardial cIB. As aforementioned, in normotensive, non-diabetic obese adults, circulating procollagen type III aminopeptide has been shown to be associated with insulin resistance. Recent cardiac magnetic resonance contrast-enhanced T1 mapping has also provided evidence that diffuse myocardial fibrosis in diabetic patients contributes to systolic and diastolic ventricular dysfunction.[35, 36]
Several limitations to this study warrants discussion. Firstly, the small number of patients with glucose intolerance and diabetes limits the statistical power to perform subgroup analysis. Further large scale studies of paediatric obese subjects are required to clarify the relationships between markers of myocardial fibrosis, insulin resistance, and glucose homeostasis. Secondly, the modality of T1 mapping, which is ideal for assessment of diffuse myocardial fibrosis, is not available to us. It is worth noting, however, that conditions other than fibrosis may also influence extracellular volume measurements by T1 mapping. Thirdly, we have not determined circulating markers of collagen synthesis in the present study. The cardiac origin of these collagen synthesis biomarkers is difficult to ascertain. More importantly, their levels vary with age and growth, which may confound the interpretation in paediatric studies. Allometric indexation using approximate powers has been shown to allow more accurate normalization of LV mass  and quantification of arterial load and ventricular-arterial coupling  in obese subjects. It would have been ideal to adopt a similar approach in this study. However, a large scale study to define a priori the normal relationships between parameters of myocardial deformation and body size is required before allometric indexation is possible. We have nonetheless compared the BMI indexed in an allometric manner between the two groups and showed significant differences. Finally, differences among ethnic groups may potential exist due to interactions of genetic, physiological, cultural, socioeconomic, and environmental factors in the pathogenesis of obesity.[40, 41] Whether the results of the present study apply to obese adolescents of other ethnicities require further clarification.
In conclusion, our findings suggest increased myocardial fibrosis in obese adolescents, which is related to measures of adiposity and may have implications on subclinical LV systolic and diastolic function. Whether weight reduction and anti-fibrotic strategies such as aldosterone antagonism may alter myocardial acoustic properties and improve myocardial deformation in young subjects are topics for further studies.
Conceived and designed the experiments: YFC PTC. Performed the experiments: LJX EM. Analyzed the data: LJX EM PTC YFC. Contributed reagents/materials/analysis tools: EM PTC YFC. Wrote the paper: LJX EM PTC YFC.
- 1. de Onis M, Blössner M, Borghi E (2010) Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 92:1257–1264. pmid:20861173
- 2. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113:898–918. pmid:16380542
- 3. Alpert MA (2001) Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome. Am J Med Sci 321:225–236. pmid:11307864
- 4. Zaman AK, Fujii S, Goto D, Furumoto T, Mishima T, Nakai Y, et al. (2004) Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity. J Mol Cell Cardiol 37:525–535. pmid:15276022
- 5. Leopoldo AS, Sugizaki MM, Lima-Leopoldo AP, do Nascimento AF, Luvizotto Rde A, de Campos DH (2010) Cardiac remodeling in a rat model of diet-induced obesity. Can J Cardiol 26:423–429. pmid:20931095
- 6. Quilliot D, Alla F, Böhme P, Bruntz JF, Hammadi M, Dousset B, et al. (2005) Myocardial collagen turnover in normotensive obese patients: relation to insulin resistance. Int J Obes (Lond) 29:1321–1328.
- 7. Abel ED, Litwin SE, Sweeney G (2008) Cardiac remodeling in obesity. Physiol Rev 88:389–419. pmid:18391168
- 8. Cavalera M, Wang J, Frangogiannis NG (2014) Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res 164:323–335. pmid:24880146
- 9. Martínez-Martínez E, Jurado-López R, Valero-Muñoz M, Bartolomé MV, Ballesteros S, Luaces M, et al. (2014) Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity. J Hypertens 32:1104–1114. pmid:24695395
- 10. Pérez JE, Miller JG, Holland MR, Wickline SA, Waggoner AD, Barzilai B, et al. (1994) Ultrasonic tissue characterization: integrated backscatter imaging for detecting myocardial structural properties and on-line quantitation of cardiac function. Am J Card Imaging 8:106–112. pmid:8032182
- 11. Kosmala W, Przewlocka-Kosmala M, Wojnalowicz A, Mysiak A, Marwick TH (2012) Integrated backscatter as a fibrosis marker in the metabolic syndrome: association with biochemical evidence of fibrosis and left ventricular dysfunction. Eur Heart J Cardiovasc Imaging 13:459–467. pmid:22185752
- 12. Leonardi B, Giglio V, Sanders SP, Pasceri V, De Zorzi A (2010) Ultrasound tissue characterization of the myocardium in patients after Kawasaki disease. Pediatr Cardiol 31:766–772. pmid:20390262
- 13. Aurigemma GP, de Simone G, Fitzgibbons TP (2013) Cardiac remodeling in obesity. Circ Cardiovasc Imaging 6:142–152. pmid:23322729
- 14. Shah AM, Solomon SD (2012) Myocardial deformation imaging: current status and future directions. Circulation 125:e244–248. pmid:22249531
- 15. Cheung YF (2014) Functional Assessment for Congenital Heart Disease. Korean Circ J 44:59–73. pmid:24653734
- 16. Forsey J, Friedberg MK, Mertens L (2013) Speckle tracking echocardiography in pediatric and congenital heart disease. Echocardiography 30:447–459. pmid:23551605
- 17. Cheung YF, Hong WJ, Chan GC, Wong SJ, Ha SY (2010) Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy. Heart 96:1137–1141. pmid:20511624
- 18. Vogel M, Schmidt MR, Kristiansen SB, Cheung M, White PA, Sorensen K, et al. (2002) Validation of myocardial acceleration during isovolumic contraction as a novel noninvasive index of right ventricular contractility: comparison with ventricular pressure-volume relations in an animal model. Circulation 105:1693–1699. pmid:11940549
- 19. Yu W, Li SN, Chan GC, Ha SY, Wong SJ, Cheung YF (2013) Transmural strain and rotation gradient in survivors of childhood cancers. Eur Heart J Cardiovasc Imaging 14:175–182. pmid:22802431
- 20. American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35:S64–S71. pmid:22187472
- 21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419. pmid:3899825
- 22. Chirinos JA, Segers P, De Buyzere ML, Kronmal RA, Raja MW, De Bacquer D, et al. (2010) Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 56:91–98. pmid:20458004
- 23. Cittadini A, Mantzoros CS, Hampton TG, Travers KE, Katz SE, Morgan JP, et al. (1999) Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity. Circulation 100:2177–2183. pmid:10571977
- 24. Hayden MR, Sowers JR (2011) Childhood-adolescent obesity in the cardiorenal syndrome: lessons from animal models. Cardiorenal Med 1:75–86. pmid:22294984
- 25. Kosmala W, Plaksej R, Przewlocka-Kosmala M, Kuliczkowska-Plaksej J, Bednarek-Tupikowska G, Mazurek W (2008) Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function. Int J Obes (Lond) 32:763–771.
- 26. Kosmala W, Przewlocka-Kosmala M, Szczepanik-Osadnik H, Mysiak A, Marwick TH (2013) Fibrosis and cardiac function in obesity: a randomised controlled trial of aldosterone blockade. Heart 99:320–326. pmid:23343682
- 27. Barbosa JA, Mota CC, Simões E Silva AC, Nunes Mdo C, Barbosa MM (2013) Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the value of speckle tracking imaging. Eur Heart J Cardiovasc Imaging 14:882–889. pmid:23291394
- 28. Labombarda F, Zangl E, Dugue AE, Bougle D, Pellissier A, Ribault V, et al. (2013) Alterations of left ventricular myocardial strain in obese children. Eur Heart J Cardiovasc Imaging 14:668–676. pmid:23161790
- 29. Taniguchi K, Kawamaoto T, Kuki S, Masai T, Mitsuno M, Nakano S, et al. (2000) Left ventricular myocardial remodeling and contractile state in chronic aortic regurgitation. Clin Cardiol 23:608–614. pmid:10941548
- 30. Dai Z, Aoki T, Fukumoto Y, Shimokawa H (2012) Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure. J Cardiol 60:416–421. pmid:22867802
- 31. Di Salvo G, Pacileo G, Del Giudice EM, Natale F, Limongelli G, Verrengia M, et al. (2008) Atrial myocardial deformation properties in obese nonhypertensive children. J Am Soc Echocardiogr 21:151–156. pmid:17628397
- 32. Katzmarzyk PT, Srinivasan SR, Chen W, Malina RM, Bouchard C, Berenson GS (2004) Body mass index, waist circumference, and clustering of cardiovascular disease risk factors in a biracial sample of children and adolescents. Pediatrics 114:e198–205. pmid:15286257
- 33. Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, Silikiotou N, et al. (2000) Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 24:1453–1458. pmid:11126342
- 34. Peterson LR, Waggoner AD, Schechtman KB, Meyer T, Gropler RJ, Barzilai B, et al. (2004) Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 43:1399–1404. pmid:15093874
- 35. Ng AC, Auger D, Delgado V, van Elderen SG, Bertini M, Siebelink HM, et al. (2012) Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T1 mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study. Circ Cardiovasc Imaging 5:51–59. pmid:22135399
- 36. Jellis C, Wright J, Kennedy D, Sacre J, Jenkins C, Haluska B, et al. (2011) Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy. Circ Cardiovasc Imaging 4:693–702. pmid:21946703
- 37. Shah RV, Abbasi SA, Neilan TG, Hulten E, Coelho-Filho O, Hoppin A, et al. (2013) Myocardial tissue remodeling in adolescent obesity. J Am Heart Assoc 2:e000279. pmid:23963758
- 38. Trivedi P, Risteli J, Risteli L, Hindmarsh PC, Brook CG, Mowat AP (1991) Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders. Pediatr Res 30:276–280. pmid:1945568
- 39. Chirinos JA, Rietzschel ER, De Buyzere ML, De Bacquer D, Gillebert TC, Gupta AK, et al. (2009) Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension 54:558–566. pmid:19581507
- 40. Caprio S, Daniels SR, Drewnowski A, Kaufman FR, Palinkas LA, Rosenbloom AL, et al. (2008) Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment: a consensus statement of Shaping America's Health and the Obesity Society. Diabetes Care 31:2211–2221. pmid:18955718
- 41. Fesinmeyer MD, North KE, Ritchie MD, Lim U, Franceschini N, Wilkens LR, et al. (2013) Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study. Obesity 21:835–846. pmid:23712987